Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

COH PEER ANALYSIS

Cochlear Ltd — metric-by-metric comparison with peers and the industry median

COHCochlear Ltd

🇦🇺 Australia · AU · Healthcare · Medical Devices

Value itDuel
PriceFinancialsPeers

Overall Profile & Returns

· Medical Devices

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityGrowthFinancial HealthDividend
COHIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
COH-56.9%LIVN+83.4%IRTC-10.1%BIO+18.4%GKOS+48.5%HAE-0.3%
Year-to-Date (YTD)
COH-50.6%LIVN+35.8%IRTC-29.5%BIO-3.5%GKOS+33.4%HAE-6.6%
1-Year
Split-adjusted
COH-56.9%4DX+1,741.7%
Year-to-Date (YTD)
COH-50.6%4DX+12.5%

Key Metric Comparison

P/E

Lower is better
COH24.11LIVN43.61IRTC—BIO46.71GKOS—HAE35.57Median 27.09

ROE

Higher is better
COH18.1%LIVN9.5%IRTC-22.4%BIO2.5%GKOS-26.4%HAE12.0%Median -8.6%

Net Margin

Higher is better
COH14.6%LIVN7.5%IRTC-3.5%BIO6.5%GKOS-34.3%HAE7.3%Median -5.7%

Revenue Growth

Higher is better
COH2.0%LIVN12.4%IRTC27.4%BIO1.9%GKOS36.3%HAE-2.0%Median 7.4%

P/E

Lower is better
COH24.114DX—Median 27.09

ROE

Higher is better
COH18.1%4DX—Median -8.6%

Net Margin

Higher is better
COH14.6%4DX-3,684.6%Median -5.7%

Revenue Growth

Higher is better
COH2.0%4DX-26.0%Median 7.4%

All Metrics

Valuation
MetricCOHLIVNIRTCBIOGKOSHAEInd. Median
P/E24.11●43.61—46.71—35.5727.09
P/B4.303.8625.221.15●13.034.352.51
EV/EBITDA15.11●20.71337.0916.39—15.8515.39
P/S3.533.265.163.0415.852.59●2.62
Financial Health
MetricCOHLIVNIRTCBIOGKOSHAEInd. Median
Current Ratio2.461.335.173.215.43●2.953.28
Debt/Equity22.1%27.6%452.4%20.1%15.4%●153.8%44.7%
NetDebt/EBITDA0.42-0.95●14.26-0.401.213.490.82
Profitability
MetricCOHLIVNIRTCBIOGKOSHAEInd. Median
Net Margin14.6%●7.5%-3.5%6.5%-34.3%7.3%-5.7%
ROE18.1%●9.5%-22.4%2.5%-26.4%12.0%-8.6%
ROA12.4%●4.2%-2.9%1.7%-20.4%4.0%-6.4%
EBITDA Margin24.0%●15.0%1.6%18.1%-26.1%21.0%5.2%
Growth + Dividend
MetricCOHLIVNIRTCBIOGKOSHAEInd. Median
Rev. Growth2.0%12.4%27.4%1.9%36.3%●-2.0%7.4%
NI Growth-6.8%●————-42.0%16.7%
Div. Yield3.6%●——1.0%——1.1%
Payout81.5%——46.4%——39.0%
Valuation
MetricCOH4DXInd. Median
P/E24.11—27.09
P/B4.30-77.13●2.51
EV/EBITDA15.11—15.39
P/S3.53●252.892.62
Financial Health
MetricCOH4DXInd. Median
Current Ratio2.466.57●3.28
Debt/Equity22.1%-22.6%●44.7%
NetDebt/EBITDA0.42●0.710.82
Profitability
MetricCOH4DXInd. Median
Net Margin14.6%●-3,684.6%-5.7%
ROE18.1%—-8.6%
ROA12.4%●-264.3%-6.4%
EBITDA Margin24.0%●-818.8%5.2%
Growth + Dividend
MetricCOH4DXInd. Median
Rev. Growth2.0%●-26.0%7.4%
NI Growth-6.8%—16.7%
Div. Yield3.6%—1.1%
Payout81.5%—39.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on COH

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.